{"componentChunkName":"component---src-templates-lie-template-tsx","path":"/lie/24117/","result":{"pageContext":{"id":"24117","location":"Twitter","claim":"“Also just ended all rebates to middlemen, further reducing [drug] prices.”","analysis":"Drug prices have largely stayed the same, and have risen for branded prescription drugs, during Trump's term. He signed an executive order in July 2020 calling for new restrictions on the \"rebates\" some middlemen receive as part of the Medicare Part D program, but the actual regulations were not finalized until November 2020, and <a target=\"_blank\" href=\"https://www.hhs.gov/about/news/2020/11/20/fact-sheet-trump-administration-finalizes-proposal-to-lower-drug-costs.html\">will not take effect until 2022</a>. It's unclear whether the industry practice of working with middlemen and rebates will abate, or if it does, whether drug prices will go down as a result.","pinocchios":"","category":"Health care","repeated_ids":"","repeated_count":"0","date":"09/13/2020","portfolio":"lie"}},"staticQueryHashes":["3649515864"]}